therapeutic window. This study aimed to resume evidence on the subject.
Objectives: The surgical management of carotid artery (CA) stenosis in women remains a subject of much controversy. The benefit of carotid endarterectomy (CEA) and CA stenting (CAS) in women has been questioned by some studies, with others demonstrating increased periprocedural rates of stroke and death. Despite much attention paid to the topic, few studies have looked at the restenosis and reintervention rates in women as compared to men following CEA and CAS. Given that the natural history of stroke in women tends to be more severe with more disabling outcomes, it is imperative to shed more light on this controversial subject.
Methods: We conducted a retrospective study of patients with CA stenosis who underwent CEA or CAS over a 6-year period (2009) (2010) (2011) (2012) (2013) (2014) (2015) at the University of Chicago Medical Center. Exclusion criteria included patient ineligible for CA intervention, those with CA stenosis not due to atherosclerosis (dissection, radiation, fibromuscular dysplasia), as well as patients without postoperative ultrasound data. Primary outcome of interest was CA restenosis, defined as a change in the ultrasound category from 0% to 49% to 50% to 79% or 80% to 99% or occlusion. Secondary outcomes included 30-day incidence of transient ischemic attack /stroke, myocardial infarction and death. The study was approved by the Institutional Review Board. Data for this study were provided by the Clinical Research Data Warehouse, maintained by the Center for Research Informatics at the University of Chicago. Data analysis was conducted using R 3.2.2 software (R Project for Statistical Computing, Vienna, Austria) and manual record review. Statistical associations between gender and variables were measured using Student t-tests for continuous variables and c 2 tests for categoric variables.
Results: A total of 150 patients were included in the study, out of which 80 (53%) were women and 70 (47%) were men. Groups were similar in terms of age, race and comorbidities. Eight women (10%) and two men (2.86%) suffered restenosis, although this was not statistically significant (P ¼ .155). Among those who underwent CEA, six women (8%) and two men (3.17%) suffered restenosis (P ¼ .400). Among those who underwent CAS, two women (40%) and no men (0%) suffered restenosis (P ¼ .295). There were no significant differences in 30-day morbidity or mortality among groups.
Conclusions: Although women are at a threefold higher risk of postoperative restenosis following carotid artery interventions, this was not statistically significant in our single-institution experience.
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Objectives: High (anatomic and physiologic) risk criteria have been identified as associated with worsened outcomes for carotid endarterectomy (CEA). We examined the effect of "high-risk" criteria on the outcomes of CEA at a single academic medical center.
Methods: We performed a retrospective analysis of a prospectively collected database of all patients undergoing CEA at a single institution from 2012 to 2015. High-risk patients were defined by the presence of one or more anatomic or physiologic risk factors for carotid intervention outlined by the Centers for Medicare and Medicaid Services. The primary end point of the study was composite stroke, myocardial infarction, or death at 30 days and composite stroke or death on follow-up. Data were analyzed with Student t-test and Fisher exact test where appropriate.
Results: A total of 385 CEA procedures were performed with a mean age of 68.9 6 0.5 years, with 67% male. Fifty-six patients (14.5%) were considered high risk, with physiologic and anatomic risk factors present for 25 and 36 patients, respectively. All 30-day and follow-up outcomes are detailed in the Table. The 30-day primary end point was 3.6% for high-risk patients and 4.6% for standard risk patients. The median follow-up was 16.3 (interquartile range, 3.2-30.9 ) months for the standard-risk group and 14.0 (interquartile range, 1.1-31.4) months for highrisk patients. The rate of death or stroke on follow-up was 10.7% for the high-risk group and 9.7% for the standard-risk group.
Conclusions: One in seven patients treated with CEA are considered as high risk. Despite the presence of high-risk factors, there were no differences in outcomes of CEA during the perioperative period or on follow-up. The findings suggest that nonpatient factors (such as procedural volume) can attenuate the effect of patient risk factors in carotid revascularization. Further analysis should be performed of these nonpatient factors to improve the outcomes after CEA. 
